MRM Health raises €55 million Series B to advance microbiome-based biotherapeutic product pipeline
Gilead Sciences breaks ground on new manufacturing and technical development site in US
Biocytogen and Merck to advance antibody-conjugated lipid-based delivery solutions
Congruence gets $32 million financing to advance genetic obesity candidate drug
Alcon India launches Unity VCS/CS for vitreoretinal and cataract surgery
Ichnos Glenmark Innovation receives upfront payment of $700 million from AbbVie
SPL Infusion commences commercial production of new IV fluid Infusion plant
Aptar Pharma partners with Dianosic to advance ARIS platform for treatment of chronic allergic rhinitis and rhinosinusitis
FDA approves sBLA for Takeda's Vonvendi for Von Willebrand disease
USFDA conducts product specific pre-approval inspection at Lupin’s Aurangabad facility
Teva received Fast Track designation from the U.S. Food and Drug Administration for emrusolmin (TEV-56286), an investigational treatment for Multiple System Atrophy (MSA) in Phase 2 development
Subscribe To Our Newsletter & Stay Updated
Chasing Consistency: Centralizing operations data is the key to optimizing chemicals plants
Implementing a digital transformation in chemical operations to maximize profitability
The complexity of compliance
The Sprint to the Summit: Unlocking Lab Efficiency through Digital Transformation
The guiding role of fluidized and spouted bed technologies in particle building processes
